Applications of N-Epsilon-Formyl-L-Lysine in Industrial Manufacturing

N-Epsilon-Formyl-L-Lysine serves as a specialty intermediate in high-value chemical and biotechnological industries. As a direct manufacturer, our facility supplies this compound to a select range of downstream sectors where precise formulation, strict compliance, and advanced processing are essential for the integrity and performance of end products.

1. Peptide Synthesis for Pharmaceutical Ingredient Manufacturing

N-Epsilon-Formyl-L-Lysine enables the selective modification of lysine residues during the stepwise synthesis of complex peptides, particularly for active pharmaceutical ingredient (API) development. Integration of N-formyl protection facilitates site-specific conjugation and subsequent deprotection, ensuring high purity and controlled reactivity. Our clients in the peptide drug field require consistently narrow impurity profiles, so we maintain validated analytical support and batch traceability. Our material aligns with the requirements for injectable and oral peptide API synthesis lines, especially in GMP-compliant settings.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• USP/NF and EP raw material monograph recommendations (where applicable)
• FDA 21 CFR Part 210/211 for pharmaceutical manufacture
• EU GMP Annex 1 for sterile production (if applicable to peptides)

Typical usage ratio

• 5–20 mol% relative to lysine residues per peptide chain, adjusted according to sequence length and number of formylation sites

Downstream process integration

• Introduced during amino acid coupling steps at the solid-phase peptide synthesis (SPPS) stage
• Removed by mild acidolysis in post-synthesis processing to furnish deprotected peptides

Final product types

• Active pharmaceutical peptide ingredients for metabolic, oncological, and endocrine therapies
• Peptide-based diagnostic agents
• Specialty peptide APIs for research and clinical trial lots

2. Biochemical Reagent Manufacturing

This raw material is essential in the production of biochemical research reagents, especially for the preparation of standard reference compounds for protein modification studies. Laboratories and reagent manufacturers use it as a formyl-lysine standard, crucial for analytical method development, antibody generation, and enzymatic activity assays targeting formylated lysine modifications.

Industry compliance standards

• ISO 9001:2015 Quality Management for laboratory reagent production
• ISO/IEC 17025 for laboratory reference material accreditation
• Establishment of Certificate of Analysis (COA) and traceability documentation

Typical usage ratio

• 0.01–0.1% (w/w) as analytical standard in reagent formulations, depending on assay sensitivity requirements

Downstream process integration

• Added during the blending and standardization of protein modification kits
• Used in preparation of calibration curves for mass spectrometry and immunoassays

Final product types

• Protein post-translational modification analysis kits
• Antibody production kits for research use
• Certified formyl-lysine reference standards
• Enzymatic assay substrates for academic and biotechnology labs

3. Diagnostic Assay Component Production

N-Epsilon-Formyl-L-Lysine is integrated into key manufacturing steps for specific immunoassay controls and calibrators. Its unique side-chain modification allows downstream diagnostic manufacturers to mimic natural or disease-related protein markers. These products support accurate ELISA, Western blot, and LC-MS-based detection of lysine formylation in clinical samples, with strict adherence to quality and traceability requirements for in vitro diagnostic (IVD) materials.

Industry compliance standards

• ISO 13485:2016 for medical device and IVD manufacturing
• FDA 21 CFR Part 820 (Quality System Regulation) for diagnostic product manufacturers
• CLSI guidelines for reference material preparation

Typical usage ratio

• 0.05–0.5% (w/v) in calibrator or control matrices, adjusted by detection limit and assay configuration

Downstream process integration

• Added at the sample preparation or protein modification stages in IVD reagent formulation lines
• Utilized in the QC spiking of calibrators for routine assay validation

Final product types

• ELISA and CLIA controls specific for formyl-lysine targets
• Immunoblot calibration materials
• Mass spectrometry calibrators for post-translational modification detection

4. Functional Food Ingredient and Nutraceutical R&D

Our customers in food ingredient research utilize N-Epsilon-Formyl-L-Lysine as a model compound for studying Maillard reaction products and their impact on protein structure and nutritional quality. Though not approved as a commercial food additive, it is permitted for controlled research under food safety laboratory requirements, supporting innovation in protein fortification and processing behavior studies in functional foods.

Industry compliance standards

• ISO 22000:2018 Food Safety Management Systems (applicable in research settings)
• FAO/WHO Codex Alimentarius General Principles for Food Additives (for research only)
• Country-specific laboratory research approvals (e.g., GRAS-notification exempt for academic food science)

Typical usage ratio

• 0.005–0.02% (w/w) in model protein systems, tailored to simulate physiological concentrations

Downstream process integration

• Introduced during simulated thermal processing of protein blends
• Analyzed post-incubation to assess nutritional and structural changes for R&D documentation

Final product types

• Model protein hydrolysates for research
• Analytical standards for Maillard reaction research
• Reference material panels for protein fortification studies in functional food development